Literature DB >> 22628158

Screening for DSM-IV-TR cognitive disorder NOS in Parkinson's disease using the Mattis Dementia Rating Scale.

Gregory M Pontone1, Justin Palanci, James R Williams, Susan Spear Bassett.   

Abstract

OBJECTIVE: This study explores the utility of the Mattis Dementia Rating Scale (MDRS) as a screening tool for the Diagnostic and Statistical Manual for Mental Disorders 4th edition (DSM-IV-TR) diagnosis cognitive disorder not otherwise specified (NOS) in Parkinson's disease (PD).
METHODS: A total of 125 individuals with PD were diagnosed using DSM-IV-TR criteria for cognitive disorder NOS and dementia. Receiver operating characteristics (ROC) tested the discriminant validity of the MDRS, with the clinician's diagnosis serving as the gold standard.
RESULTS: The MDRS ROC curve to discriminate subjects with cognitive disorder NOS from non-demented subjects had an area under the curve of 0.59 (standard error = 0.08, 95% CI: 0.43-0.74).
CONCLUSIONS: The MDRS is not effective for identifying PD patients with cognitive disorder NOS without dementia.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22628158      PMCID: PMC3449223          DOI: 10.1002/gps.3833

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  27 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Is PD-MCI a useful concept?

Authors:  Bruno Dubois
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

3.  Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.

Authors:  M N Sabbagh; T Lahti; D J Connor; J N Caviness; H Shill; L Vedders; P Mahant; J Samanta; R S Burns; V G H Evidente; E Driver-Dunckley; B Reisberg; S Bircea; C H Adler
Journal:  Dement Geriatr Cogn Disord       Date:  2007-09-13       Impact factor: 2.959

4.  Normative data for the Mattis Dementia Rating Scale.

Authors:  J A Lucas; R J Ivnik; G E Smith; D L Bohac; E G Tangalos; E Kokmen; N R Graff-Radford; R C Petersen
Journal:  J Clin Exp Neuropsychol       Date:  1998-08       Impact factor: 2.475

Review 5.  Cognitive deficits in Parkinson's disease.

Authors:  B Dubois; B Pillon
Journal:  J Neurol       Date:  1997-01       Impact factor: 4.849

6.  Cognitive profile of patients with newly diagnosed Parkinson disease.

Authors:  Dino Muslimovic; Bart Post; Johannes D Speelman; Ben Schmand
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

Authors:  Cindy Zadikoff; Susan H Fox; David F Tang-Wai; Teri Thomsen; Rob M A de Bie; Pettarusup Wadia; Janis Miyasaki; Sarah Duff-Canning; Anthony E Lang; Connie Marras
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

9.  Defining mild cognitive impairment in Parkinson's disease.

Authors:  John N Caviness; Erika Driver-Dunckley; Donald J Connor; Marwan N Sabbagh; Joseph G Hentz; Brie Noble; Virgilio Gerald H Evidente; Holly A Shill; Charles H Adler
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

Review 10.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

Authors:  C H Williams-Gray; T Foltynie; C E G Brayne; T W Robbins; R A Barker
Journal:  Brain       Date:  2007-05-29       Impact factor: 13.501

View more
  5 in total

Review 1.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

2.  Effect of isoflurane + N2O inhalation and propofol + fentanyl anesthesia on myocardial function as assessed by cardiac troponin, caspase-3, cyclooxygenase-2 and inducible nitric oxide synthase expression.

Authors:  Zhuanghui Zhu; Shuanglian Yi; Zhonggui Shan; Hongwei Guo; Shaofan Ke
Journal:  Exp Ther Med       Date:  2017-08-25       Impact factor: 2.447

3.  Multiculturalism: A Challenge for Cognitive Screeners in Parkinson's Disease.

Authors:  Marta Statucka; Kirsten Cherian; Alfonso Fasano; Renato P Munhoz; Melanie Cohn
Journal:  Mov Disord Clin Pract       Date:  2021-05-27

Review 4.  A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures.

Authors:  Isobel T French; Kalai A Muthusamy
Journal:  Front Aging Neurosci       Date:  2016-05-23       Impact factor: 5.750

5.  Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Shuxia Qian; Keliang Chen; Qiaobing Guan; Qihao Guo
Journal:  BMC Neurol       Date:  2021-04-21       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.